Incrediwear ACL MCL Arthroscopic Surgery Recovery Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Garrett Steinmetz, MD · PRINCIPAL_INVESTIGATOR · Oklahoma Joint Reconstruction Institute
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Subjective Patient Pain Experience180 days
The Visual Analogue Scale (VAS), a 0 to 10 scale, with 0 being no pain and 10 being the worst pain will be used to measures pain intensity.
- Pain Medication Usage180 days
Patient will document pain medication type and quantity taken in a daily pain diary.
- Effusion/swelling Measurements180 days
The Patella sweep test is used to measure effusion. The measured rating is a quantity on a scale of 0 to 3, with 0 rating no fluid-wave while perorming a downward stroke, 1 a large bulge, 2 medial fluid returns to position without performing a downward sweep, and 3 excell of fluid that makes it impossible to stroke the medial fluid away. Measurements will be taken at set times during the postoperative period.
- Range of Motion180 days
The patient's range of motion captured at all time points during the postoperative period.